| Application no. and date | 99934914.5 (espacenet) (Federated) (European Patent Register), 19990721 | | Patent/reg. no. and date | DK/EP 1098639, 20050209 | | Publication date | 20010516 | | Priority no. and date | GB 9815871, 19980721, GB 9815872, 19980721, GB 9905387, 19990309 | | EP pub. no. and date |
EP 1098639 20010516 | | Effective date | | | Applicant/owner | SmithKline Beecham plc, 980 Great West Road
Brentford,
Middlesex TW8 9GS, GB,
Laboratoire GlaxoSmithKline S.A.S., 100, route de Versailles
78163 Marly-le-Roi Cedex, FR | | Applicant ref. no. | P200500435 EP DK | | Inventor | BRIL, Antoine, M. A., c/o GlaxoSmithKline
980 Great West Road
Brendford
Middlesex TW8 9GS, GB,
BUCKINGHAM, Robin, Edwin, c/o GlaxoSmithKline
980 Great West Road venue
Brendford
Middlesex TW8 9GS, GB,
KHANDOUDI, Nassirah, c/o GlaxoSmithKline
980 Great West Road B.P. 58
Brendford
Middlesex TW8 9GS, FR | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/425 (2006.01) , A61K 31/44 (2006.01) , A61P 9/10 (2006.01) | | Title | Anvendelse af glucoseoptagelsesforstærkeren rosiglitazon til reduktion af iskæmiinduceret apoptose af pankreatiske beta-celler, endotelceller og neuronale celler | | Int. application no. | GB1999002361 | | Int. publication no. | WO2000004890 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
